News

Here's Why Viking Therapeutics Bounced Back Today

Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data ...

Viking Therapeutics Shares Nosedive Toward Worst Day Ever After Obesity Trial Data

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.
MarketBeat on MSN11h

Is Viking's Growth Still Worth the Premium?

Viking (NYSE: VIK) stock is down approximately 3% after the cruise line’s second-quarter earnings report. The company ...

Viking's Premium Valuation Backed By Strong Growth, Analyst Notes

Viking Holdings Ltd (NYSE:VIK) shares slipped on Wednesday despite the cruise operator posting a strong second-quarter ...

Why Viking Therapeutics stock reaction to obesity pill data is wildly ‘overdone’

Viking Therapeutics Inc (NASDAQ: VKTX) reported new clinical data for its oral obesity drug – sending shares sharply lower as ...

Viking Therapeutics Stock Plunges on Oral Weight-Loss Pill Study Results

Viking Therapeutics reported a large number of patients dropped out of a study of its experimental weight-loss pill.

Viking Therapeutics Slumps as Weight-Loss Pill Study Underwhelms

Viking Therapeutics Inc. plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage ...

Viking Therapeutics: Phase 2 Oral Obesity Data Affirms Bear Case, Downgrade To Sell

Viking Therapeutics, Inc.'s obesity drug VK2735 results reveal no clear edge over leading competitors. Click for why this ...

Ancient ‘Viking diet’ makes a comeback: Here's what to know before you try it

The modern Viking diet emphasizes whole foods over ultraprocessed options, with experts recommending home cooking and ...

Cruise Operator Viking Falls as Pricing Power Tapers Off

Viking Holdings Ltd. shares fell as the cruise line operator is facing constraints on how much it can charge for its journeys ...